<p>Avanos Medical（纽约证券交易所代码：AVNS - 获取免费报告）在周一发布给客户和投资者的研究报告中，被 Zacks Research 的投资分析师从 “强烈卖出” 评级上调至 “持有” 评级，Zacks.com 报道。</p>
<p>获取 <strong>Avanos Medical</strong> 的提醒：</p>
<p>其他一些股票研究分析师最近也对 AVNS 发布了报告。Weiss Ratings 在 12 月 22 日的研究报告中重新发布了对 Avanos Medical 股票的 “卖出（d-）” 评级。华尔街 Zen 在 11 月 8 日的研究报告中将 Avanos Medical 的评级从 “买入” 上调至 “强烈买入”。一位研究分析师对该股票给予了 “持有” 评级，另一位则给予了 “卖出” 评级。根据 MarketBeat.com 的数据，该股票的共识评级为 “减持”。</p>
<p><strong>查看我们对 Avanos Medical 的最新股票分析</strong></p>
<h2>Avanos Medical 价格表现</h2>
<p>AVNS 股票在周一开盘价为$13.14。Avanos Medical 的 52 周低点为$9.30，52 周高点为$17.69。该公司的速动比率为 1.36，流动比率为 2.38，债务与股本比率为 0.12。该股票的市值为 609.73 百万美元，市盈率为-1.29，贝塔值为 1.08。该公司的 50 日移动平均线为$11.78，200 日移动平均线为$11.63。</p>
<p>Avanos Medical（纽约证券交易所代码：AVNS - 获取免费报告）最近于 11 月 5 日发布了季度财报。该公司报告本季度每股收益为$0.22，超出分析师的共识预期$0.12，超出幅度为$0.10。该公司本季度的收入为$177.80 百万，而分析师预期为$164.50 百万。Avanos Medical 的股本回报率为 6.21%，净利润率为-67.00%。与去年同期相比，该公司的收入增长了 4.3%。在去年同期，该公司每股收益为$0.33。Avanos Medical 已将其 2025 财年的指导目标设定为每股收益 0.850-0.950。整体来看，研究分析师预计 Avanos Medical 在当前年度的每股收益为 1.32。</p>
<h2>Avanos Medical 的内部活动</h2>
<p>在其他 Avanos Medical 的新闻中，高级副总裁 Kerr Holbrook 于 11 月 18 日星期二出售了 15,000 股该公司的股票。股票以平均价格$11.00 出售，总价值为$165,000.00。交易完成后，该高级副总裁在公司持有 83,860 股，价值$922,460。这笔交易使他们的持股减少了 15.17%。该交易已在 SEC 的法律文件中披露，相关信息可在 SEC 网站上获取。目前，2.64% 的股票由公司内部人士持有。</p>
<h2>机构资金流入和流出</h2>
<p>一些对冲基金和其他机构投资者最近买卖了该股票的股份。AQR Capital Management LLC 在第一季度将其在 Avanos Medical 的持股增加了 46.4%。AQR Capital Management LLC 现在拥有 192,864 股该公司的股票，价值$2,700,000，在上个季度又购买了 61,095 股。MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.在第一季度将其在 Avanos Medical 的持股增加了 4.3%。MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.现在拥有 26,955 股该公司的股票，价值$386,000，在上个季度又收购了 1,121 股。Millennium Management LLC 在第一季度将其在 Avanos Medical 的持股增加了 508.3%。Millennium Management LLC 现在拥有 547,740 股该公司的股票，价值$7,849,000，在上个季度又收购了 457,703 股。Empowered Funds LLC 在第一季度将其在 Avanos Medical 的持股增加了 5.4%。Empowered Funds LLC 现在拥有 162,182 股该公司的股票，价值$2,324,000，在上个季度又收购了 8,348 股。最后，UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC 在第一季度将其在 Avanos Medical 的持股增加了 17.1%。UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC 现在拥有 140,810 股该公司的股票，价值$2,018,000，在上个季度又购买了 20,541 股。目前，95.17% 的股票由对冲基金和其他机构投资者持有。</p>
<h2>Avanos Medical 公司简介</h2>
<p>（获取免费报告）</p>
<p>Avanos Medical 是一家全球医疗技术公司，开发和销售广泛的医疗设备组合，旨在改善医院、门诊和急性后护理环境中的患者结果。该公司的产品专注于三个核心治疗领域——疼痛管理、肠内喂养和呼吸护理——旨在帮助临床医生管理术后疼痛、提供营养支持并协助各种急性和慢性病症患者的呼吸。</p>
<p>在其疼痛管理领域，Avanos 提供非阿片类药物输送系统和冷冻镇痛设备，包括门诊输注泵和冷却射频消融平台。</p>
<h2>进一步阅读</h2>
<ul>
<li>我们更看好的五只股票比 Avanos Medical 更好</li>
<li>美国下一个权力行动从地下开始</li>
<li>您的签名缺失 - 在为时已晚之前采取行动</li>
<li>新法律：国会批准数字美元的设立？</li>
<li>1933 年的退款：特朗普的重置可能创造即时财富</li>
<li>黄金市场历史上最大的骗局正在解开</li>
</ul>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或评论发送至 contact@marketbeat.com。</em></p>
<h2>您现在应该投资$1,000 在 Avanos Medical 吗？</h2>
<p>在您考虑 Avanos Medical 之前，您需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已经识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 Avanos Medical 并不在名单上。</p>
<p>虽然 Avanos Medical 目前在分析师中被评为减持，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

AVNS

<p>Zacks Research 将 Avanos Medical (NYSE:AVNS) 的评级从 “强烈卖出” 上调至 “持有”。其他分析师的观点不一，Weiss Ratings 维持 “卖出” 评级，而 Wall Street Zen 则上调至 “强烈买入”。Avanos Medical 的股票开盘价为 13.14 美元，52 周范围为 9.30 至 17.69 美元。该公司报告了上个季度每股收益为 0.22 美元，超出预期，并预计 2025 财年的每股收益在 0.850 至 0.950 之间。最近的内部交易包括高级副总裁 Kerr Holbrook 出售了 15,000 股股票。95.17% 的股票由机构投资者持有</p>

<p>Avanos Medical (NYSE:AVNS - Get Free Report) was upgraded by investment analysts at Zacks Research from a &#34;strong sell&#34; rating to a &#34;hold&#34; rating in a research report issued to clients and investors on Monday,Zacks.com reports.</p>
<div class="lb-trans"><p>Avanos Medical（纽约证券交易所代码：AVNS - 获取免费报告）在周一发布给客户和投资者的研究报告中，被 Zacks Research 的投资分析师从 “强烈卖出” 评级上调至 “持有” 评级，Zacks.com 报道。</p>
</div><p>Get <strong>Avanos Medical</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>Avanos Medical</strong> 的提醒：</p>
</div><p>A number of other equities research analysts also recently issued reports on AVNS. Weiss Ratings reissued a &#34;sell (d-)&#34; rating on shares of Avanos Medical in a research note on Monday, December 22nd. Wall Street Zen raised Avanos Medical from a &#34;buy&#34; rating to a &#34;strong-buy&#34; rating in a research report on Saturday, November 8th. One research analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the company's stock. According to MarketBeat.com, the stock has a consensus rating of &#34;Reduce&#34;.</p>
<div class="lb-trans"><p>其他一些股票研究分析师最近也对 AVNS 发布了报告。Weiss Ratings 在 12 月 22 日的研究报告中重新发布了对 Avanos Medical 股票的 “卖出（d-）” 评级。华尔街 Zen 在 11 月 8 日的研究报告中将 Avanos Medical 的评级从 “买入” 上调至 “强烈买入”。一位研究分析师对该股票给予了 “持有” 评级，另一位则给予了 “卖出” 评级。根据 MarketBeat.com 的数据，该股票的共识评级为 “减持”。</p>
</div><p><strong>View Our Latest Stock Analysis on Avanos Medical</strong></p>
<div class="lb-trans"><p><strong>查看我们对 Avanos Medical 的最新股票分析</strong></p>
</div><h2>Avanos Medical Price Performance</h2>
<div class="lb-trans"><h2>Avanos Medical 价格表现</h2>
</div><p>AVNS stock opened at $13.14 on Monday. Avanos Medical has a 52-week low of $9.30 and a 52-week high of $17.69. The company has a quick ratio of 1.36, a current ratio of 2.38 and a debt-to-equity ratio of 0.12. The stock has a market cap of $609.73 million, a price-to-earnings ratio of -1.29 and a beta of 1.08. The business has a fifty day moving average of $11.78 and a two-hundred day moving average of $11.63.</p>
<div class="lb-trans"><p>AVNS 股票在周一开盘价为$13.14。Avanos Medical 的 52 周低点为$9.30，52 周高点为$17.69。该公司的速动比率为 1.36，流动比率为 2.38，债务与股本比率为 0.12。该股票的市值为 609.73 百万美元，市盈率为-1.29，贝塔值为 1.08。该公司的 50 日移动平均线为$11.78，200 日移动平均线为$11.63。</p>
</div><p>Avanos Medical (NYSE:AVNS - Get Free Report) last released its quarterly earnings results on Wednesday, November 5th. The company reported $0.22 earnings per share for the quarter, topping analysts' consensus estimates of $0.12 by $0.10. The business had revenue of $177.80 million during the quarter, compared to analysts' expectations of $164.50 million. Avanos Medical had a positive return on equity of 6.21% and a negative net margin of 67.00%.The company's revenue was up 4.3% compared to the same quarter last year. During the same period in the prior year, the business posted $0.33 EPS. Avanos Medical has set its FY 2025 guidance at 0.850-0.950 EPS. As a group, research analysts anticipate that Avanos Medical will post 1.32 earnings per share for the current year.</p>
<div class="lb-trans"><p>Avanos Medical（纽约证券交易所代码：AVNS - 获取免费报告）最近于 11 月 5 日发布了季度财报。该公司报告本季度每股收益为$0.22，超出分析师的共识预期$0.12，超出幅度为$0.10。该公司本季度的收入为$177.80 百万，而分析师预期为$164.50 百万。Avanos Medical 的股本回报率为 6.21%，净利润率为-67.00%。与去年同期相比，该公司的收入增长了 4.3%。在去年同期，该公司每股收益为$0.33。Avanos Medical 已将其 2025 财年的指导目标设定为每股收益 0.850-0.950。整体来看，研究分析师预计 Avanos Medical 在当前年度的每股收益为 1.32。</p>
</div><h2>Insider Activity at Avanos Medical</h2>
<div class="lb-trans"><h2>Avanos Medical 的内部活动</h2>
</div><p>In other Avanos Medical news, SVP Kerr Holbrook sold 15,000 shares of the business's stock in a transaction on Tuesday, November 18th. The shares were sold at an average price of $11.00, for a total value of $165,000.00. Following the completion of the transaction, the senior vice president owned 83,860 shares in the company, valued at $922,460. The trade was a 15.17% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. 2.64% of the stock is currently owned by company insiders.</p>
<div class="lb-trans"><p>在其他 Avanos Medical 的新闻中，高级副总裁 Kerr Holbrook 于 11 月 18 日星期二出售了 15,000 股该公司的股票。股票以平均价格$11.00 出售，总价值为$165,000.00。交易完成后，该高级副总裁在公司持有 83,860 股，价值$922,460。这笔交易使他们的持股减少了 15.17%。该交易已在 SEC 的法律文件中披露，相关信息可在 SEC 网站上获取。目前，2.64% 的股票由公司内部人士持有。</p>
</div><h2>Institutional Inflows and Outflows</h2>
<div class="lb-trans"><h2>机构资金流入和流出</h2>
</div><p>A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. AQR Capital Management LLC increased its holdings in Avanos Medical by 46.4% in the first quarter. AQR Capital Management LLC now owns 192,864 shares of the company's stock valued at $2,700,000 after buying an additional 61,095 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its holdings in shares of Avanos Medical by 4.3% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 26,955 shares of the company's stock valued at $386,000 after acquiring an additional 1,121 shares during the last quarter. Millennium Management LLC raised its position in shares of Avanos Medical by 508.3% during the 1st quarter. Millennium Management LLC now owns 547,740 shares of the company's stock worth $7,849,000 after acquiring an additional 457,703 shares in the last quarter. Empowered Funds LLC raised its position in shares of Avanos Medical by 5.4% during the 1st quarter. Empowered Funds LLC now owns 162,182 shares of the company's stock worth $2,324,000 after acquiring an additional 8,348 shares in the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its stake in Avanos Medical by 17.1% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 140,810 shares of the company's stock worth $2,018,000 after purchasing an additional 20,541 shares during the last quarter. 95.17% of the stock is currently owned by hedge funds and other institutional investors.</p>
<div class="lb-trans"><p>一些对冲基金和其他机构投资者最近买卖了该股票的股份。AQR Capital Management LLC 在第一季度将其在 Avanos Medical 的持股增加了 46.4%。AQR Capital Management LLC 现在拥有 192,864 股该公司的股票，价值$2,700,000，在上个季度又购买了 61,095 股。MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.在第一季度将其在 Avanos Medical 的持股增加了 4.3%。MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.现在拥有 26,955 股该公司的股票，价值$386,000，在上个季度又收购了 1,121 股。Millennium Management LLC 在第一季度将其在 Avanos Medical 的持股增加了 508.3%。Millennium Management LLC 现在拥有 547,740 股该公司的股票，价值$7,849,000，在上个季度又收购了 457,703 股。Empowered Funds LLC 在第一季度将其在 Avanos Medical 的持股增加了 5.4%。Empowered Funds LLC 现在拥有 162,182 股该公司的股票，价值$2,324,000，在上个季度又收购了 8,348 股。最后，UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC 在第一季度将其在 Avanos Medical 的持股增加了 17.1%。UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC 现在拥有 140,810 股该公司的股票，价值$2,018,000，在上个季度又购买了 20,541 股。目前，95.17% 的股票由对冲基金和其他机构投资者持有。</p>
</div><h2>Avanos Medical Company Profile</h2>
<div class="lb-trans"><h2>Avanos Medical 公司简介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Avanos Medical is a global medical technology company that develops and markets a broad portfolio of medical devices intended to improve patient outcomes in hospital, outpatient and post-acute care settings. The company's products focus on three core therapy areas—pain management, enteral feeding and respiratory care—designed to help clinicians manage post-operative pain, deliver nutrition support and assist breathing for patients across a variety of acute and chronic conditions.</p>
<div class="lb-trans"><p>Avanos Medical 是一家全球医疗技术公司，开发和销售广泛的医疗设备组合，旨在改善医院、门诊和急性后护理环境中的患者结果。该公司的产品专注于三个核心治疗领域——疼痛管理、肠内喂养和呼吸护理——旨在帮助临床医生管理术后疼痛、提供营养支持并协助各种急性和慢性病症患者的呼吸。</p>
</div><p>In its pain management segment, Avanos offers both non-opioid drug delivery systems and cryoanalgesia devices, including ambulatory infusion pumps and cooled radiofrequency ablation platforms.</p>
<div class="lb-trans"><p>在其疼痛管理领域，Avanos 提供非阿片类药物输送系统和冷冻镇痛设备，包括门诊输注泵和冷却射频消融平台。</p>
</div><h2>Further Reading</h2>
<div class="lb-trans"><h2>进一步阅读</h2>
</div><ul>
<li>Five stocks we like better than Avanos Medical</li>
<li>America's Next Power Move Starts Underground</li>
<li>Your Signature Is Missing – Act Before It’s Too Late</li>
<li>NEW LAW: Congress Approves Setup For Digital Dollar?</li>
<li>Refund From 1933: Trump’s Reset May Create Instant Wealth</li>
<li>The biggest scam in the history of gold markets is unwinding</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票比 Avanos Medical 更好</li>
<li>美国下一个权力行动从地下开始</li>
<li>您的签名缺失 - 在为时已晚之前采取行动</li>
<li>新法律：国会批准数字美元的设立？</li>
<li>1933 年的退款：特朗普的重置可能创造即时财富</li>
<li>黄金市场历史上最大的骗局正在解开</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或评论发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Avanos Medical Right Now?</h2>
<div class="lb-trans"><h2>您现在应该投资$1,000 在 Avanos Medical 吗？</h2>
</div><p>Before you consider Avanos Medical, you'll want to hear this.</p>
<div class="lb-trans"><p>在您考虑 Avanos Medical 之前，您需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Avanos Medical wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已经识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 Avanos Medical 并不在名单上。</p>
</div><p>While Avanos Medical currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Avanos Medical 目前在分析师中被评为减持，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Avanos Medical（NYSE:AVNS）在 Zacks Research 的评级被上调至 “持有”